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Value of patient-reported symptoms in the
diagnosis of transient loss of consciousness
ABSTRACT
Objective: Epileptic seizures, syncope, and psychogenic nonepileptic seizures (PNES) account for
over 90% of presentations with transient loss of consciousness (TLOC). The patient’s history is
crucial for the diagnosis, but the diagnostic value of individual semiologic features is limited. This
study explores the diagnostic potential of a comprehensive questionnaire focusing on TLOC-
associated symptoms.
Methods: A total of 386 patients with proven epilepsy, 308 patients with proven PNES, and 371
patients with proven syncope were approached by post to recruit 100 patients in each diagnostic
group. Symptoms were self-reported on an 86-item questionnaire (the Paroxysmal Event Profile
[PEP]) using a 5-point Likert scale (always to never). Data were subjected to exploratory factor
analysis (EFA) followed by confirmatory factor analysis (CFA). Factors were used to differentiate
between diagnoses by pairwise and multinomial regression.
Results: Patients with PNES reported more and more frequent TLOC-associated symptoms than
those with epilepsy or syncope (p, 0.001). EFA/CFA identified a 5-factor structure based on 74/
86 questionnaire items with loadings $0.4. Pairwise logistic regression analysis correctly clas-
sified 91% of patients with epilepsy vs those with syncope, 94% of those with PNES vs those
with syncope, and 77% of those with epilepsy vs those with PNES. Multinomial logistic regres-
sion analysis yielded a similar pattern.
Conclusions: Clusters of self-reported TLOC symptoms can be used to direct patients to appro-
priate investigation and treatment pathways for syncope on the one hand and seizures on the
other, although additional information is required for a reliable distinction, especially between epi-
lepsy and PNES. Neurology® 2016;87:625–633
GLOSSARY
ANOVA 5 analysis of variance; CFA 5 confirmatory factor analysis; CFI 5 Comparative Fit Index; DSM-IV-TR 5 Diagnostic
and Statistical Manual of Mental Disorders, 4th edition, text revision; EFA 5 exploratory factor analysis; PEP 5 paroxysmal
event profile; PNES 5 psychogenic nonepileptic seizures; RMSEA 5 root mean square error approximation; TLI 5 Tucker
Lewis Index; TLOC 5 transient loss of consciousness.
Transient loss of consciousness (TLOC) is the second most common neurologic emergency.1
Three conditions account for over 90% of presentations: epilepsy and psychogenic nonepileptic
seizures (PNES) and syncope.2,3 Accurate distinction among these conditions is crucial because
treatment choice depends on it. However, misdiagnosis rates of over 25% have been reported in
different primary and secondary care settings.4–6 The gold standard test in this situation would
be the synchronous recording of a typical event by video, heart rhythm by ECG, and electrical
brain activity by EEG. However, in many patients, the observation of spontaneous episodes of
TLOC is impractical or impossible.
Previous research suggests that there is no single demographic, clinical, or semiologic feature
that distinguishes clearly among epilepsy, syncope, and PNES.4,7 In routine clinical practice, the
diagnosis is usually based on a combination of facts derived from the patient’s history and
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witness accounts (if available). The diagnosis
also takes account of interictal investigations
like blood pressure recordings, ECG, EEG,
and brain CT or MRI, although these inves-
tigations are of limited utility.8–11 However, in
the absence of a clear pretest probability of one
specific cause of TLOC, interictal test abnor-
malities may be misinterpreted, especially by
nonexperts.5,6,12
The misdiagnosis of PNES is particularly
common. In fact, almost all patients with this
disorder initially receive a diagnosis of epilepsy
or syncope.13,14 The mean latency between
manifestation and diagnosis of PNES is 4–7
years, putting patients at risk of inappropriate
emergency treatments and even death.13,15,16
For these reasons, recent epilepsy manage-
ment guidelines emphasize the need for an
early expert assessment.17 However, access to
experts is limited, and even experts currently
lack evidence-based tools that would allow
them to express the level of certainty with
which they have made their initial clinical
diagnosis: an accurate determination of a post-
test probability of a particular diagnosis would
require a clear understanding of its pretest
probability.18
The present study determines whether
a comprehensive profile of patients’ TLOC
experiences can contribute to the differentia-
tion among the 3 common causes of this clin-
ical phenomenon and explores whether such
a questionnaire can provide a pretest probabil-
ity adding value to the interpretation of inter-
ictal investigations.
METHODS Patients: Epilepsy and PNES groups. Patients
with epilepsy or PNES supported by video-EEG recordings of
typical seizures involving TLOC were identified from clinical
databases of the Department of Clinical Neurophysiology at
the Royal Hallamshire Hospital in Sheffield and the National
Hospital of Neurology and Neurosurgery in London, United
Kingdom.
Syncope group. Patients with a diagnosis of recurrent syncope
supported by pathophysiologic evidence (typical warning symptoms
or complete TLOC associated with typical heart rate or blood pressure
changes during a tilt-table test/presyncopal or syncopal symptoms
associated with explanatory heart rate or rhythm changes during
ECG monitoring) were identified from the centers above and the
database of the Falls and Syncope Service based at Newcastle upon
Tyne, United Kingdom.
Patients with one of the causes of TLOC were approached by
post until 100 in each diagnostic group had returned completed
questionnaires. The clinical diagnoses of all patients were confirmed
by each patients’ consultant neurologist/physician. All patients were
$16 years of age at the time of the study.
Sample size. We recruited a total sample of n 5 300 (100 per
group) to allow us to conduct factor analyses across all partici-
pants as well as to test for moderate differences (effect size$0.40)
between groups with at least 80% power.19
Paroxysmal event profile (PEP). The 86-item PEP included
questions previously shown to differentiate between tonic-clonic
seizures and syncope.20,21 It also included questions thought by
experts, among whom earlier versions of this questionnaire were
circulated, potentially to differentiate between epilepsy and
PNES. Additional items were based on ideas derived from
metaphor analytic studies suggesting that patients with epilepsy
perceive their episodes of TLOC as opponents with independent
agency whereas those with PNES experience their TLOC as
a space or place they themselves go through.22,23 The PEP also
contained questions about dissociation (based on the Dissociative
Experience Scale Taxon)24 and about symptoms of panic listed in
the DSM-IV-TR.25 Responses were invited on a 5-point Likert
scale (always/frequently/sometimes/rarely/never). In addition to
the 86 items focusing on TLOC manifestations, respondents
were asked to answer 7 questions about demographic and
clinical features (see PEP questionnaire, appendix e-1 on the
Neurology® Web site at Neurology.org, for details).
Study procedure. PEP questionnaires were sent out by post
with a free return envelope and an information sheet stating that
the return of the completed questionnaire would be interpreted as
consent. Patients were incentivized to return the questionnaires
by the offer of participation in a prize draw for a digital radio
(value £60, $80).
Statistical analysis. Overall mean symptom scores for each par-
ticipant were calculated for each diagnostic group and compared
using analysis of variance (ANOVA). Frequencies of reporting ex-
tremes (never or always responses) were tabulated and compared
between diagnostic groups using x2 statistics.
An exploratory factor analysis (EFA) of the PEP items was con-
ducted using geomin oblique rotation. Items with factor loadings
$0.4 were retained. In a confirmatory factor analysis (CFA), the
factor structure suggested by the EFA was subjected to Goodness of
Fit statistics, including root mean square error approximation
(RMSEA), Comparative Fit Index (CFI), and Tucker Lewis Index
(TLI). RMSEA ,0.06, CFI .0.90, and TLI .0.90 were prede-
termined as standards for good model fitting.
Mean factor scores were compared across the 3 diagnostic
groups and differences tested using 1-way ANOVA. To assess the
ability of all of the factors simultaneously to discriminate partici-
pants by diagnostic groups, pairwise and multinomial logistic
regression analyses were used with all 5 factor scores as continuous
predictors. Separate models including models using only one factor
score at a time were also produced. In addition to regression models
based entirely on self-reported TLOC symptom factors, we report
regression models combining TLOC symptom factors with addi-
tional patient demographic/clinical information (self-reported data
on sex, number of episodes of TLOC in the last year, lifetime num-
ber of hospitalizations, and whether or not there had been any ad-
missions to intensive care for the treatment of TLOC or whether
there was a family history of TLOC). All clinical variables were
included as categorical predictors (as in table 1). Age and age at
onset were not included in models including patients with syncope
because syncope patients were predominantly recruited in a health
care setting attracting older adults.
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All factor analyses were conducted in Mplus version 7.0.
Logistic regression was performed in SAS (SAS Institute, Cary,
NC) version 9.3 for Windows. Two-sided p values #0.05 were
considered statistically significant. The ANOVA on 86 items was
controlled for multiple testing (i.e., significance was determined
at 0.05/86 5 0.00058).
Standard protocol approvals, registrations, and patient
consents. Ethical approval for this study was granted by the
Northern and Yorkshire Multi-Centre Research Ethics Committee.
Patients were informed that their return of the completed PEP
questionnaire would be considered as consent to the analysis and
publication of the data provided.
RESULTS Respondents. A total of 386 patients with
epilepsy, 308 with PNES, and 371 with syncope were
approached until 100 patients had been recruited in
each group (see table 1).
Descriptive findings. The mean item scores for each
PEP question by the 3 diagnostic groups are presented
in figure 1. As indicated by the darker shading of
the PNES column in figure 1, patients in this group
reported more frequent symptoms overall (mean score
2.4, where 1 is never and 5 is always) than those with
epilepsy (mean score 2.0) or syncope (mean score 1.8,
differences: PNES vs epilepsy p , 0.0001, epilepsy vs
syncope p 5 0.007). PNES were also associated with
a wider range of symptoms, reflected by the lower
number of white squares in the PNES column in
figure 1 and by the lower mean percentage of never
replies in the PNES group (46.1%) than the epilepsy
(60.3%) or syncope (73.4%) groups (differences PNES
vs epilepsy p , 0.0001, epilepsy vs syncope p ,
0.0001). As indicated by the significantly lower percent-
age of extremes (i.e., never plus always), PNES (59.4%)
emerged as a less stereotyped phenomenon than epilepsy
(70.4%) or syncope (82.9%, differences PNES vs epi-
lepsy p , 0.0001, epilepsy vs syncope p , 0.0001).
Table 1 Overview of demographic and clinical characteristics of the 3 respondent groups (continuous
variables are shown as means [SD] and discrete variables as counts)
Epilepsy (n 5 100) PNES (n 5 100) Syncope (n 5 100) p Value
Age, y 35.4 (14.5) 41.6 (13.5) 53.5 (21.6) ,0.0001a
Age at onset, y 12.2 (11.4) 26.4 (15.2) 39.4 (25.0) ,0.0001a
Duration, y 23.2 (13.6) 15.0 (15.9) 14.1 (16.8) ,0.0001b
Sex
Female 71 71 77 0.54c
Male 29 29 23
TLOC in last yeard
None 17 10 21 ,0.0001a
Up to 5 18 7 50
Up to 50 31 40 25
More than 50 31 43 4
Hospitalizatione,f
Never 32 23 82 ,0.0001g
Once 17 16 7
Up to 5 19 29 10
More than 5 31 27 1
Intensive caree
No 84 84 99 0.0005g
Yes 16 16 1
Family history
No 72 71 76 0.70c
Yes 28 29 24
Abbreviations: PNES 5 psychogenic nonepileptic seizures; TLOC 5 transient loss of consciousness.
aSelf-reported lifetime number of hospitalizations with TLOC.
bNo. of TLOC unknown in 3 patients with epilepsy.
cHospitalization information for 1 patient with epilepsy and 5 with PNES is missing.
dAll 3 pairwise comparisons had p , 0.05.
eAll except PNES vs syncope comparisons had p , 0.05.
fNone of 3 pairwise comparisons had p , 0.05.
gAll except PNES vs epilepsy comparisons had p , 0.05.
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Figure 1 Range and frequency of self-reported transient loss of consciousness symptoms in patients with
epilepsy, syncope, and psychogenic nonepileptic seizures (PNES)
Graphic representation of the respondents’ mean answers to the 86 questions posed in the paroxysmal event profile (PEP)
illustrates the relative diagnostic value of individual items. Mean answers are indicated for each group by the light blue line.
The shade of the background color also indicates the mean response (with dark shades reflecting more frequent experi-
ences and light shades less frequent experiences).
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Responses to 57 out of 76 items differed signifi-
cantly among the 3 diagnostic groups in an ANOVA
(p # 0.0005). Only 10 items (P2, P5, P8, P10, P20,
P26, P34, P74, P80, and P84) did not differentiate
among the 3 groups, even at the more liberal 0.05
level.
Latent factor analysis. EFA models with 1–6 factors
were tested due to there being 6 eigenvalues greater
than 1. Models with 4–6 factors all had a good model
fit (RMSEA #0.05 and CFI/TLI $0.90), but the
5-factor model was favored for its better interpretability.
Of the 86 items, 74 had factor loadings$0.4. Seven
loaded on 2, the remaining items on 1 latent factor.
The 5-factor structure, with the selected 74 items,
was tested by CFA. The fit indices of CFA model were
CFI 5 0.93, TLI 5 0.92, and REMSA 5 0.04.
Based on our semantic interpretation, the 5 latent
factors were called feeling overpowered, sensory
experience, mind/body/world disconnection, cata-
strophic experience, and amnesia (see table 2 for more
details). The mean factor scores from the CFA anal-
ysis across the epilepsy (E), PNES (P), and syncope
(S) groups are shown in figure 2. The factors feeling
overpowered, mind/body/world disconnection, and
catastrophic experience were significantly different
among all 3 groups (p , 0.001), while amnesia only
differentiated syncope and sensory experience only
epilepsy from the other 2 diagnostic groups (p ,
0.001) (see table 3 for more details).
Differential diagnostic value of latent factors. Initial pair-
wise logistic regression established the discriminating
power of the factors between each pair of the 3 possi-
ble clinical diagnoses (table 4). The combination of
symptom-based factor scores and basic patient
demographic/clinical information (excluding age
and age at onset) correctly classified more patients
than the symptom-based data alone. In each
regression, the factor scores (based on patients’ self-
reported seizure experiences) contributed more to the
differential diagnosis than patient demographic/clinical
information.
Multinomial logistic regression analysis revealed
a similar pattern to the analyses described above: 91
out of 100 (91%) syncope diagnoses could be predicted
correctly. Correct classification rates were lower for epi-
lepsy and PNES: 63 out of 96 (66%) epilepsy patients
and 74 out of 95 (78%) PNES patients were classified
correctly, and most of the confounding was between
these 2 diagnostic categories as well (the PNES and epi-
lepsy groups contained fewer than 100 patients because
some demographic/clinical details had not been pro-
vided by a small number of participants).
DISCUSSION Our study demonstrates that a com-
prehensive self-report tool focusing on TLOC-
associated symptoms can differentiate with high
accuracy between syncope and the other 2 common
causes of TLOC and slightly less well between PNES
and epilepsy. This finding is of considerable clinical
importance because it shows that self-reported
symptom profiles can help direct patients to the most
appropriate specialist services and provide a numeric
pretest probability enhancing the diagnostic value of
interictal investigations.
While to date, no diagnostic self-report tool
designed to aid the differentiation among the 3 com-
mon causes of TLOC has been tested, a 118-item
questionnaire used in 671 patients achieved a correct
differentiation between recurrent generalized tonic
clonic seizures or syncope in 94% of cases.21 How-
ever, patients with loss of awareness without collapse
or those with PNES were excluded from this study.
In another study, a 29-item patient questionnaire
was used in combination with a 6-item witness ques-
tionnaire to identify patients who ultimately
received an expert diagnosis of epileptic seizure from
a group of 94 patients with TLOC. A logistic regres-
sion model based on 4 items (age, sweating before
the event, tongue biting, and witnessed rapid
Table 2 Five latent factors: Sample questions contributing to the different factors
Factor name
No. of items loading
onto factors Item numbers loading onto factors Typical items
Feeling overpowered 10 p2, p8–p13, p17, p18, p65 p9. My attacks well up inside me. p17. Just before my
attacks I feel anxious or nervous.
Sensory experience 11 p1, p3, p4, p16, p19–p22, p24–p26 P24. In my attacks my vision goes dim or dark. P25. In
my attacks sounds are distorted.
Amnesia 11 p1, p34, p45, p76, p77, p80–p83, p85, p86 P82. After my attacks I feel very confused. P83.
Afterwards I have no idea that I have had an attack.
Mind/body/world disconnection 27 p11, p14, p15, p26–p29, p32, p36,
p38–p40, p42–p44, p46–p56, p60
P43. During an attack, I feel as if other people, objects,
and the world are not real. P50. During my attacks I feel
as if I’m not a person. P51. During my attacks I feel as if
I’m not in the living world.
Catastrophic experience 22 p21, p23, p31, p33, p35, p37, p41, p55,
p56, p58, p61–p64, p66–p70, p73,
p78, p81
P41. I am aware of shaking uncontrollably during an
attack. P69. My attacks are painful, like a hammer blow.
P70. My attacks feel like a knife through the head.
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orientation after the event) worked least well in
uncertain cases.20
Another project (excluding those with probable
syncope) used a 209-item questionnaire in patients
referred for video-EEG with possible diagnoses of epi-
lepsy or PNES. This self-report tool categorized pa-
tients correctly with a sensitivity and specificity of
85%.26 While a small proportion of questions used
in this study asked about subjective seizure symp-
toms, other studies suggest that the subjective expe-
riences and patients’ accounts of PNES differ from
those of epileptic seizures.23,27–32
It is a particular strength of our study that the clin-
ical diagnoses of all participants had been proven by
the recording of typical TLOC episodes during appro-
priate physiologic monitoring. Previous studies aiming
to validate diagnostic questionnaires have often used
much lower diagnostic standards, for instance the
working diagnosis after a certain period of follow-
up,20,21 the opinion of an experienced clinician,33 or
the diagnosis recorded in medical registers.34,35 Given
how important the patient’s history is for the diagnosis,
validation studies not involving objective confirmation
by the recording of a typical episode of TLOC are at
risk of demonstrating a match between a clinician’s
history-taking efforts and a history taken by question-
naire rather than a match between the actual diagnosis
and the diagnostic questionnaire result. Having said
this, the fact that we deliberately chose patients with
medical gold standard diagnoses means that our find-
ings were based on a relatively chronic patient popu-
lation. Now that there is clear proof-of-concept that
a symptom-based questionnaire can contribute to the
Table 3 ANOVA demonstrating the differentiating potential of individual factor
scores among the 3 possible causes of TLOC
Diagnosis Diagnosis
Factor difference
estimate p Value
Feeling overpowered E P 20.05546 0.0033
E S 0.06974 0.0002
P S 0.1252 ,0.0001
Sensory experience E P 20.2203 ,0.0001
E S 20.2299 ,0.0001
P S 20.00968 0.8465
Amnesia E P 20.01703 0.4965
E S 0.2383 ,0.0001
P S 0.2553 ,0.0001
Mind/body/world disconnection E P 20.3737 ,0.0001
E S 0.5341 ,0.0001
P S 0.9078 ,0.0001
Catastrophic experience E P 20.5506 ,0.0001
E S 0.4202 ,0.0001
P S 0.9709 ,0.0001
Abbreviations: ANOVA 5 analysis of variance; E 5 epilepsy; P 5 psychogenic nonepileptic
seizures; S 5 syncope; TLOC 5 transient loss of consciousness.
Figure 2 Transient loss of consciousness (TLOC) symptom profiles in epilepsy, syncope, and psychogenic
nonepileptic seizures
Symptom profiles based on 5 latent factors characterizing the subjective patient experience of the 3 common causes of
TLOC (means and SE bars). E 5 epilepsy; P 5 psychogenic nonepileptic seizures; S 5 syncope.
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differential diagnosis of TLOC, we can use the results
of our study to identify the most highly discriminating
questions and develop a shorter questionnaire specifi-
cally for use in clinical settings where patients initially
present with TLOC.
In our study, patients with PNES reported more
different and frequent TLOC-associated symptoms
than those with epilepsy or syncope. These observa-
tions are consistent with a previous study that demon-
strated a greater range of subjective ictal experiences
in PNES than epilepsy.28 They could simply reflect
the tendency of patients with PNES to report higher
rates of physical symptoms generally—as demon-
strated by studies using general somatization meas-
ures.36,37 However, impairment of consciousness
associated with PNES may also be less profound than
that associated with the other 2 disorders.38,39 Third,
TLOC caused by PNES may be a less stereotyped
experience. This interpretation would be supported
by the lower ratio of extreme vs middling responses
seen in this group.
Our study demonstrates that self-reported symptom
profiles made a greater contribution to the diagnostic
models than the available demographic and clinical
facts, although the addition of these facts improved
the accuracy of the diagnostic models. The models
did not differentiate equally well among all 3 causes
of TLOC: our self-report tool accurately categorized
over 90% of patients with either epilepsy or syncope.
Similar levels of diagnostic separation were achieved in
the distinction of patients with PNES from those with
syncope. However, even when information derived
from symptom reports was combined with
demographic/clinical information, our detailed ques-
tionnaire only classified 77% of patients accurately
when we attempted to distinguish between epilepsy
and PNES (82% with the additional consideration of
age at onset). The high levels of correct differentiation
between syncope and epilepsy are in keeping with the
results of previous studies.20,21 However, in contrast to
the previous studies, our study includes a well-
characterized group of patients with PNES, a condition
as common in neurology clinics as syncope.2,3 This
means that our findings are applicable to a wider range
of patients, including those with partial or absence seiz-
ures involving TLOC, not only those with generalized
tonic-clonic seizures, on which the largest similar pre-
vious study focused.21
While responses to 57 of the 86 items in the PEP
questionnaire differed among the diagnostic groups,
questions asking about symptoms of disconnection
and patients’ tendency to catastrophize made the
greatest contribution to the 3-way differentiation.
Responses to these questions suggested that PNES
more than epileptic seizures and both of these types
of TLOCmore than syncope involve ictal experiences
similar to those that characterize dissociative or anx-
iety disorders.
Our study has a number of limitations. Given that
we wanted to base our study on patients with gold
standard diagnoses, our findings are derived from pa-
tients who presented to specialist centers. The fact
that the participants in all diagnostic groups studied
were predominantly female meant that the groups
were well-matched for sex but also suggests that male
patients may have been underrepresented, at least in
the epilepsy group. Our findings may also have been
affected by the response rate: while a rate of around
30% may be all that is achievable in a postal study
of this kind, there may have been significant differen-
ces between patients who participated in this study
and those who did not. The relatively high number
of episodes of TLOC and long duration of TLOC
disorders is likely to have enabled respondents to
answer questions about their symptoms particularly
well. However, the preferential inclusion of patients
with relatively chronic disorders means that our find-
ings should be replicated in other settings before they
are generalized more widely. We also cannot rule out
that patients’ symptom reporting was influenced by
them being aware of their diagnosis. For instance, pa-
tients with PNES may have been encouraged by doc-
tors to reflect on the presence of dissociative or anxiety
symptoms. Finally, the differential diagnostic value of
self-reported subjective symptoms could be greater if
they had been combined with information only
obtainable from other sources, for instance from wit-
nesses. For instance, it may have been helpful to know
whether collapses were atonic or involved shaking.
Table 4 Binary logistic regression demonstrating differentiating potential of
factor scores or demographic/clinical patient information or both
combined
Outcomes and covariates No.a Sensitivity Specificity Total accuracy, %
PNES vs epilepsy
Factor scores 200 0.78 0.72 75
Patient information 191 0.74 0.46 60
Combined 191 0.80 0.74 77
Syncope vs epilepsy
Factor scores 200 0.87 0.83 85
Patient information 196 0.88 0.68 78
Combined 196 0.92 0.91 91
PNES vs syncope
Factor scores 200 0.93 0.87 90
Patient information 195 0.85 0.85 85
Combined 195 0.95 0.93 94
Abbreviation: PNES 5 psychogenic nonepileptic seizures.
aDemographic or clinical information was missing for some of the patients who were not
included in these analyses.
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Despite these limitations, our study clearly demon-
strates that the different pathophysiologic mechanisms
causing TLOC in epilepsy, PNES, and syncope are
associated with different TLOC experiences. Self-
reported TLOC manifestations differentiate well
between patients with syncope and those with seiz-
ures. However, the distinction of epileptic from non-
epileptic seizures was less secure. Self-report tools
based on TLOC manifestations can therefore be used
to guide patients to relevant medical investigation and
treatment pathways (e.g., cardiology for syncope, neu-
rology for seizures) and can help to quantify the post-
test probability of particular diagnoses.
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CORRECTION
Value of patient-reported symptoms in the diagnosis of transient loss of consciousness
In the article “Value of patient-reported symptoms in the diagnosis of transient loss of consciousness” by M. Reuber et al.,1
there are errors in the figure. The syncope and epilepsy labels were switched and in addition, item 3 should read “Sight of
blood” rather than “Site of blood” as originally published. The corrected figure is below. The authors regret the errors.
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